| Literature DB >> 25165481 |
Mert Ilhan1, Burçin Ergene2, Ipek Süntar1, Serkan Ozbilgin2, Gülçin Saltan Çitoğlu2, M Ayşe Demirel3, Hikmet Keleş4, Levent Altun2, Esra Küpeli Akkol1.
Abstract
The aim of the present research is to evaluate the antiurolithiatic effect of the various extracts prepared from the fruits of Viburnum opulus L., in regard to its ethnobotanical record. To induce urolithiasis, 70 mg/kg sodium oxalate was injected to the rats which were housed individually in metabolic cages. The test materials were applied during 7 days. Biochemical (urine and serum parameters), histopathological and antioxidant (TBARs, TSH and GSH) assays were conducted. The urine samples were examined by light microscope for the determination of the calcium oxalate crystals. Lyophilized juice of V. opulus (LJVO) and lyophilized commercial juice of V. opulus (LCJVO) exerted potential antiurolithiatic activity which was attributed to its diuretic effect along with the inhibitory action on the oxalate levels and free radical production. We also determined the chlorogenic acid content of the LJVO by high-performance liquid chromatography (HPLC). Chlorogenic acid was determined by using Supelcosil LC-18 (250 × 4.6 mm, 5 µm) column and acetonitrile: water: 0.2% o-phosphoric acid as a mobile phase. The chlorogenic acid content of V. opulus was found to be 0.3227 mg/mL in fruit juice. The results obtained in this study have provided a scientific evidence for the traditional usage of V. opulus on passing kidney stones in Turkish folk medicine.Entities:
Year: 2014 PMID: 25165481 PMCID: PMC4137613 DOI: 10.1155/2014/578103
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
| Time (min) | Water (0.02% | Acetonitrile % |
|---|---|---|
| 0 | 94 | 6 |
| 25 | 70 | 30 |
| 30 | 70 | 30 |
| 30,01 | 0 | 100 |
| 35 | 0 | 100 |
Column: Supelcosil LC-18 (250 × 4.6 mm, 5 μm).
Mobile phase: water (0.02% o-phosphoric acid) and acetonitrile were used in gradient elution.
Flow rate: 1 mL/min.
Detection: 254 nm (diode-array detector).
Injection volume: 10 μL.
Effect of the test samples on the urine parameters.
| Groups | Unit | Statistical mean ± S.E.M. | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Vehicle | NaOx | Hexane extract | EtOAc extract | MeOH extract | LJVO | LCJVO | Cystone | ||
| Creatinine | mg/dL | 2.27 ± 0.09 | 4.25 ± 0.17 | 4.16 ± 0.09 | 3.97 ± 0.09 | 3.45 ± 0.27 | 2.95 ± 0.24∗ | 2.25 ± 0.19∗ | 1.39 ± 0.10∗∗ |
| Urea nitrogen | mg/dL | 18.42 ± 1.75 | 25.75 ± 0.98 | 28.59 ± 1.53 | 18.98 ± 1.43 | 21.14 ± 0.96 | 14.32 ± 1.17 | 13.23 ± 0.93∗ | 11.17 ± 0.84∗ |
| Uric acid | mg/dL | 0.37 ± 0.83 | 2.97 ± 0.56 | 2.95 ± 0.97 | 2.55 ± 1.16 | 2.06 ± 1.03 | 1.96 ± 0.95 | 1.79 ± 0.81 | 1.63 ± 0.75 |
| Sodium | mEq/L | 108.25 ± 3.76 | 128.51 ± 2.59 | 111.67 ± 2.09 | 100.25 ± 3.27 | 125.75 ± 2.19 | 107.12 ± 3.22 | 80.47 ± 4.56∗∗ | 73.85 ± 2.05∗∗∗ |
| Potassium | mEq/L | 72.54 ± 2.12 | 106.1 ± 2.76 | 126.3 ± 1.86 | 89.96 ± 2.36 | 97.71 ± 3.51 | 92.55 ± 3.02 | 88.20 ± 2.54 | 68.41 ± 1.92∗ |
| Chloride | mEq/L | 85.79 ± 2.66 | 149.15 ± 2.77 | 99.63 ± 2.81 | 116.25 ± 3.59 | 108.55 ± 3.27 | 96.43 ± 2.54 | 91.02 ± 1.69 | 82.45 ± 1.60 |
| Calcium | mg/dL | 4.88 ± 0.36 | 10.20 ± 0.21 | 8.61 ± 0.48 | 5.65 ± 0.55 | 5.82 ± 0.59 | 4.92 ± 0.29 | 5.02 ± 0.22 | 4.56 ± 0.18 |
| Microalbumin | mg/L | 2.41 ± 0.08 | 7.54 ± 0.07 | 2.55 ± 0.15 | 6.10 ± 0.36 | 4.99 ± 0.84 | 1.37 ± 0.23 | 1.02 ± 0.20∗ | 0.78 ± 0.18∗∗ |
| Oxalate | mg/dL | 1.54 ± 0.11 | 2.15 ± 0.74 | 1.99 ± 0.25 | 1.77 ± 0.21 | 1.02 ± 0.18 | 0.69 ± 0.10∗∗ | 0.61 ± 0.09∗∗ | 0.59 ± 0.03∗∗∗ |
| Magnesium | mg/L | 0.16 ± 0.05 | 0.09 ± 0.02 | 0.08 ± 0.06 | 0.11 ± 0.08 | 0.15 ± 0.10 | 0.10 ± 0.04 | 0.16 ± 0.07 | 0.15 ± 0.02 |
| Volume of urine | mL | 7.66 ± 1.15 | 11.75 ± 1.21 | 12.00 ± 1.85 | 8.00 ± 1.56 | 18.00 ± 1.44∗ | 25.21 ± 0.19∗∗ | 24.00 ± 1.28∗∗ | 19.56 ± 1.53∗ |
| pH of urine | — | 7.93 ± 0.14 | 9.00 ± 0.35 | 9.00 ± 0.31 | 8.75 ± 0.39 | 9.00 ± 0.27 | 7.92 ± 0.42 | 7.66 ± 0.42 | 7.25 ± 0.35 |
| Kidney weight | g | 1.22 ± 0.09 | 2.20 ± 0.05 | 1.92 ± 0.10 | 1.93 ± 0.08 | 1.95 ± 0.09 | 1.91 ± 0.06 | 1.89 ± 0.07 | 1.87 ± 0.08 |
S.E.M.: standard error of the mean; *P < 0.05; **P < 0.01; ***P < 0.001; test groups were compared to the vehicle.
Effect of the test samples on the urine parameters.
| Groups | Vehicle | NaOx | Hexane extract | EtOAc extract | MeOH extract | LJVO | LCJVO | Cystone |
|---|---|---|---|---|---|---|---|---|
| Leukocyte | 15 | 70 | 15 | 70 | 15 | 15 | 15 | 15 |
| Nitrite | 0.7 | — | — | — | — | — | — | — |
| Urobilinogen | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
| Protein | 1 | 2 | 2.6 | 2 | 1.5 | 1 | — | — |
| Blood | 5–10 | 50 | 5–10 | 1 | 5–10 | 1 | 1 | — |
| Specific gravity | 1005 | 1030 | 1010 | 1005 | 1000 | 1000 | 1000 | 1000 |
| Ketone | — | — | — | — | — | — | — | — |
| Bilirubine | — | — | — | 1 | — | — | — | — |
| Glucose | — | — | — | — | — | — | — | — |
Figure 1Microscopic view of urine samples (the original magnification is ×400). Data are representative of 6 animals per group; NaOx administered animals Arrow pointing the CaOx crystals.
Figure 2Microscopic view of urine samples (the original magnification is ×400). Data are representative of 6 animals per group; LJVO treated group.
Figure 3Microscopic view of urine samples (the original magnification is ×400). Data are representative of 6 animals per group; LCJVO treated group.
Figure 4Microscopic view of urine samples (the original magnification is ×400). Data are representative of 6 animals per group; Cystone treated group.
Effect of the test samples on the serum parameters.
| Group | Unit | Statistical mean ± S.E.M. | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Vehicle | NaOx | Hexane extract | EtOAc extract | MeOH extract | LJVO | LCJVO | Cystone | ||
| Creatinine | mg/dL | 1.59 ± 0.04 | 4.06 ± 0.13 | 2.08 ± 0.12 | 2.26 ± 0.16 | 1.98 ± 0.07 | 1.75 ± 0.08 | 1.66 ± 0.10 | 1.46 ± 0.09 |
| Urea nitrogen | mg/dL | 11.17 ± 0.72 | 20.59 ± 1.32 | 18.89 ± 0.97 | 6.89 ± 1.07 | 9.15 ± 0.89 | 6.23 ± 0.70∗ | 5.02 ± 0.39∗∗ | 5.12 ± 0.45∗∗ |
| Uric acid | mg/dL | 1.99 ± 0.65 | 4.08 ± 0.15 | 2.05 ± 0.51 | 1.85 ± 0.05 | 2.19 ± 0.32 | 1.91 ± 0.40 | 1.88 ± 0.23 | 1.80 ± 0.16 |
| Sodium | eEq/L | 3213.42 ± 158.65 | 5144.76 ± 214.63 | 4123.48 ± 186.25 | 4486.32 ± 168.30 | 5026.42 ± 317.49 | 4073.29 ± 250.38 | 4215.82 ± 154.36 | 3961.03 ± 86.40 |
| Potassium | eEq/L | 32.62 ± 1.13 | 64.26 ± 1.08 | 44.31 ± 1.26 | 48.92 ± 1.32 | 50.76 ± 1.25 | 28.30 ± 1.02 | 30.54 ± 0.95 | 24.10 ± 0.80∗ |
| Chloride | mEq/L | 54.24 ± 2.75 | 132.73 ± 5.91 | 155.2 ± 3.67 | 81.96 ± 2.96 | 76.85 ± 3.04 | 74.17 ± 3.16 | 13.20 ± 1.91∗∗∗ | 10.35 ± 1.07∗∗∗ |
| Calcium | mg/dL | 2.74 ± 0.15 | 8.32 ± 0.39 | 7.14 ± 0.76 | 5.92 ± 0.50 | 3.85 ± 0.45 | 4.07 ± 0.36 | 2.53 ± 0.16 | 2.02 ± 0.09∗ |
S.E.M.: standard error of the mean; *P < 0.05; **P < 0.01; ***P < 0.001; test groups were compared to the vehicle.
Urolithiasis and associated histopathologic lesions in the experimental groups.
| Materials | Cf | Cdt | D | I | H | O | F | C | Hc |
|---|---|---|---|---|---|---|---|---|---|
| Vehicle | ++/+++ | ++ | +/++ | +/++ | − | −/+ | +/++ | +++ | − |
| NaOx | +++ | +/++ | ++ | + | − | −/+ | + | +/++ | − |
| Hexane extract | ++/+++ | ++/+++ | ++/+++ | ++ | − | + | + | ++ | −/+ |
| EtOAc extract | ++/+++ | ++/+++ | +++ | ++/+++ | + | + | + | +/++ | +/++ |
| MeOH extract | ++/+++ | +++ | ++/+++ | ++/+++ | − | −/+ | + | ++ | −/+ |
| LJVO | +/++ | ++ | ++ | +/++ | + | + | + | +++ | − |
| LCJVO | +/++ | + | + | + | −/+ | − | −/+ | ++ | − |
| Cystone | − | − | − | − | − | − | − | − | − |
Cf: calculi fragments; Cdt: cystic dilatation of tubules; D: degeneration; I: inflammation; H: hemorrhage; O: oedema; F: fibrosis; C: capsulitis; Hc: hyaline cylinders.
Figure 5Histopathological view of the experimental groups. Sections show the hematoxylin and eosin (HE) stained kidney. Sections were viewed using a Nicon Eclipse Ci optical microscope and polarized light. Arrows indicates renal calculus. The original magnification was ×100 and the scale bars represent 150 μm for figures in (a)–(h). (a) Vehicle; (b) NaOx; (c) n-hexane extract; (d) EtOAc extract; (e) MeOH extract; (f) LJVO; (g) LCJVO; (h) Cystone group.
TBARS, GSH, and TSH levels in kidney.
| Materials | Mean ± SD | ||
|---|---|---|---|
| TBARS | GSH | TSH | |
| (nmol/g) | ( | ( | |
| Vehicle | 266.2 ± 11.8 | 17.6 ± 1.4 | 7.7 ± 1.1 |
| NaOx | 258.8 ± 9.9 | 15.3 ± 0.9 | 7.1 ± 0.9 |
| Hexane extract | 207.3 ± 10.7 | 16.9 ± 1.2 | 5.4 ± 0.7 |
| EtOAc extract | 195.4 ± 10.4 | 15.9 ± 1.0 | 8.4 ± 1.3 |
| MeOH extract | 186.2 ± 8.4 | 19.9 ± 1.5 | 10.7 ± 1.2 |
| LJVO | 134.5 ± 6.5*** | 21.7 ± 1.2** | 15.5 ± 1.7*** |
| LCJVO | 121.1 ± 5.1*** | 24.8 ± 1.1*** | 13.65 ± 1.9** |
| Cystone | 125.5 ± 6.3*** | 25.2 ± 1.3*** | 17.4 ± 2.1*** |
**P < 0.01; ***P < 0.001.
Figure 6The HPLC chromatogram of LJVO.
Figure 7The HPLC chromatogram of chlorogenic acid.